Elucidation of the physicomechanical and ab initio quantum energy transitions of a crosslinked PLGA scaffold
Source abstract
Abstract
This study elucidated the in vitro physicomechanical transitions of a crosslinked polylactic-co-glycolic acid (PLGA) scaffold, utilizing quantum mechanics to compute the ab initio energy requirements of a salted-out and subsequently crosslinked PLGA scaffold interacting with simulated physiological fluid, phosphate buffered saline (PBS) (pH 7.4, 37 degrees C) at a molecular level. Twenty-six salted-out PLGA scaffolds were formulated using a four factor, two centerpoint quadratic Face-Centered Central Composite Design (FCCD). PLGA molecular mass, PLGA concentration, water volume and salting-out reaction time were the dependant formulation variables. Subsequent to PLGA solubilization in dimethyl formamide (DMF), protonated water was added to induce salting-out of PLGA into a scaffolds that were immersed in PBS, oscillated at 100 rpm, and analyzed at pre-determined time intervals for their physicomechanical and ab initio quantum energy transitions. Results indicated that the matrix resilience (MR) decreased with longer incubation periods (MR=35-45%) at day 30. Scaffolds salted-out using higher PLGA concentrations exhibited minimal changes in MR and the matrix ability to absorb energy was found to closely correlate with the scaffold residence time in PBS. Spartan-based ab initio quantum energy predictions elucidated the potential scaffold stability from a molecular viewpoint and its suitability for use in rate-modulated drug delivery.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (17)
Show source-provided references
1. Biodegradable polyesters for drug and polypeptide delivery
2. Potential applications of PLGA film-implants in modulating in vitro drugs release10.1016/S0378-5173(02)00431-3 ↗
3. Biodegradable microspheres as a depot system for parenteral delivery of peptide drugs10.1016/0168-3659(94)90082-5 ↗
4. Formulation in-vitro transfection efficiency of poly (d,l-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery
5. Biodegradation of aliphatic polyesters
6. Biodegradation and biocompatibility of PLA and PLGA microspheres10.1016/S0169-409X(97)00048-3 ↗
7. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application10.1081/BIO-200039635 ↗
8. Characterizing particulate drug-delivery carriers with atomic force microscopy10.1109/MEMB.2005.1384106 ↗
9. Biological activity of rhBMP-2 released from PLGA microspheres10.1115/1.429662 ↗
10. Why degradable polymers undergo surface erosion or bulk erosion10.1016/S0142-9612(02)00170-9 ↗
11. Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion?10.1016/S0939-6411(01)00130-8 ↗
12. Hydration theory for molecular biophysics10.1016/S0065-3233(02)62011-X ↗
13. Formulation and evaluation of controlled release delivery systems for the treatment of alzheimer's disease
14. Soft contact lenses capable of sustained delivery of timolol10.1002/jps.10209 ↗
15. Cochran · 1992
16. Biomimetic mineral–organic composite scaffolds with controlled internal architecture
17. Modifying the release of gentamicin from microparticles using PLGA blends10.1081/PDT-120003491 ↗